Literature DB >> 12937085

Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia.

Norma Beatriz Romero1, Nicole Monnier, Louis Viollet, Anne Cortey, Martine Chevallay, Jean Paul Leroy, Joël Lunardi, Michel Fardeau.   

Abstract

We studied seven patients (fetuses/infants) from six unrelated families affected by central core disease (CCD) and presenting with a fetal akinesia syndrome. Two fetuses died before birth (at 31 and 32 weeks) and five infants presented severe symptoms at birth (multiple arthrogryposis, congenital dislocation of the hips, severe hypotonia and hypotrophy, skeletal and feet deformities, kyphoscoliosis, etc.). Histochemical and ultrastructural studies of muscle biopsies confirmed the diagnosis of CCD showing unique large eccentric cores. Molecular genetic investigations led to the identification of mutations in the ryanodine receptor (RYR1) gene in three families, two with autosomal recessive (AR) and one with autosomal dominant (AD) inheritance. RYR1 gene mutations were located in the C-terminal domain in two families (AR and AD) and in the N-terminal domain of the third one (AR). This is the first report of mutations in the RYR1 gene involved in a severe form of CCD presenting as a fetal akinesia syndrome with AD and AR inheritances.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937085     DOI: 10.1093/brain/awg244

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  46 in total

1.  Clinical utility gene card for: Central core disease.

Authors:  Suzanne Lillis; Stephen Abbs; Clemens R Mueller; Francesco Muntoni; Heinz Jungbluth
Journal:  Eur J Hum Genet       Date:  2011-10-12       Impact factor: 4.246

2.  Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies.

Authors:  Le Xu; Ying Wang; Naohiro Yamaguchi; Daniel A Pasek; Gerhard Meissner
Journal:  J Biol Chem       Date:  2008-01-01       Impact factor: 5.157

Review 3.  Arthrogryposis: a review and update.

Authors:  Michael Bamshad; Ann E Van Heest; David Pleasure
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

4.  RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.

Authors:  Paul J Isackson; Jianxin Wang; Mohammad Zia; Paul Spurgeon; Adrian Levesque; Jonathan Bard; Smitha James; Norma Nowak; Tae Keun Lee; Georgirene D Vladutiu
Journal:  Pharmacogenomics       Date:  2018-10-16       Impact factor: 2.533

5.  Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy.

Authors:  John Rendu; Julie Brocard; Eric Denarier; Nicole Monnier; France Piétri-Rouxel; Cyriaque Beley; Nathalie Roux-Buisson; Brigitte Gilbert-Dussardier; Marie José Perez; Norma Romero; Luis Garcia; Joël Lunardi; Julien Fauré; Anne Fourest-Lieuvin; Isabelle Marty
Journal:  Hum Gene Ther       Date:  2013-07       Impact factor: 5.695

6.  Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy.

Authors:  Daniel C Helbling; David Mendoza; Julie McCarrier; Mark A Vanden Avond; Matthew M Harmelink; Paul E Barkhaus; Donald Basel; Michael W Lawlor
Journal:  J Neuropathol Exp Neurol       Date:  2019-03-01       Impact factor: 3.685

7.  Mild Clinical Features and Histopathologically Atypical Cores in Two Korean Families with Central Core Disease Harboring RYR1 Mutations at the C-Terminal Region.

Authors:  Na-Yeon Jung; Yeong-Eun Park; Jin-Hong Shin; Chang Hun Lee; Dae-Soo Jung; Dae-Seong Kim
Journal:  J Clin Neurol       Date:  2014-11-11       Impact factor: 3.077

8.  RYR1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia.

Authors:  Sherin Shaaban; Leigh Ramos-Platt; Floyd H Gilles; Wai-Man Chan; Caroline Andrews; Umberto De Girolami; Joseph Demer; Elizabeth C Engle
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

Review 9.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

10.  Single-channel properties of skeletal muscle ryanodine receptor pore Δ4923FF4924 in two brothers with a lethal form of fetal akinesia.

Authors:  Le Xu; Frederike L Harms; Venkat R Chirasani; Daniel A Pasek; Fanny Kortüm; Peter Meinecke; Nikolay V Dokholyan; Kerstin Kutsche; Gerhard Meissner
Journal:  Cell Calcium       Date:  2020-02-17       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.